Concepedia

Publication | Closed Access

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine

DOI

150

Citations

26

References

2011

Year

Richard B. Lipton, SF Varon, Brian M. Grosberg, Peter J. McAllister, F. G. Freitag, SK Aurora, David W. Dodick, Stephen D. Silberstein, Hans‐Christoph Diener, Ronald E. DeGryse,
Neurology

Abstract

This study provides Class 1A evidence that onabotulinumtoxinA treatment reduces headache impact and improves HRQoL.

References

YearCitations

Page 1